Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized Therapies

Overview

About this study

The purpose of this study is to establish a tissue bank to collect patient tissue for genomic analysis, allowing identification of genomic signatures that predict response and failure to the individual therapy.  Once this is complete treatment will be directed based on the genomic signature of patients individual tumor.

 

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult patients, ≥ 18 years of age.
  • Willing and able to complete informed consent for harvesting tissue for research.

Exclusion Criteria:

  • Patients < 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

James Jakub, M.D.

Open for enrollment

Contact information:

Pamela Skaran

(507) 538-7155

Skaran.Pamela@mayo.edu

More information

Publications

Publications are currently not available
.

Mayo Clinic Footer